Calian Group Ltd., trading under the symbol OTC:CLNFF, is a diversified company providing services in health, IT, training, and engineering. On February 12, 2026, CLNFF reported earnings per share of $0.75, surpassing the estimated $0.66. However, the company generated revenue of approximately $151.5 million, falling short of the estimated $203.1 million.
The company's price-to-earnings (P/E) ratio is approximately 39.76, indicating that investors are willing to pay $39.76 for every dollar of earnings. This suggests a high level of investor confidence in the company's future earnings potential. Despite the revenue miss, the positive earnings per share could be a factor in maintaining investor interest.
Calian's price-to-sales ratio stands at about 1.05, meaning the company's market value is slightly above its sales. This ratio, along with an enterprise value to sales ratio of 1.21, reflects a balanced valuation relative to its sales. These metrics are crucial for investors assessing the company's market position and growth potential.
The enterprise value to operating cash flow ratio is approximately 20.63, providing insight into the company's valuation relative to its cash flow. This ratio suggests that the company is valued at over 20 times its operating cash flow, which could indicate strong cash flow generation capabilities. The earnings yield of about 2.52% offers a perspective on the return on investment for shareholders.
Calian's debt-to-equity ratio is approximately 0.54, indicating a moderate level of debt compared to equity. This suggests a balanced approach to financing, with a good mix of debt and equity. Additionally, the current ratio of around 1.48 indicates that the company has a good level of liquidity to cover its short-term liabilities, which is reassuring for investors concerned about the company's financial stability.
